Coya Therapeutics, Inc. Common Stock (COYA) — Strategic Asset Allocation Index
Coya Therapeutics, Inc. Common Stock (COYA) has a Strategic Asset Allocation Index of 0.6% as of June 2023. Strategic assets (PP&E of $79.63K plus long-term investments of $-) total $79.63K, measured against net assets of $13.25 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Coya Therapeutics, Inc. Common Stock to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Coya Therapeutics, Inc. Common Stock Strategic Asset Allocation Index (2021–2021)
This chart shows how Coya Therapeutics, Inc. Common Stock's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2023, the index stands at 0.6%, representing strategic assets of $79.63K against net assets of $13.25 Million USD. For live market cap and overall valuation, see how much is Coya Therapeutics, Inc. Common Stock worth.
Annual Strategic Asset Allocation Index for Coya Therapeutics, Inc. Common Stock (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Coya Therapeutics, Inc. Common Stock from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Coya Therapeutics, Inc. Common Stock (COYA) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 3.3% | $120.67K | $120.67K | $- | $3.64 Million | — |